Targeted Talks

Follow Targeted Talks
Share on
Copy link to clipboard

Targeted Oncology brings you Targeted Talks, a monthly podcast featuring discussions with academic and community oncologists surrounding advancements in cancer research and best practices for patient management.

Targeted Talks


    • Apr 15, 2025 LATEST EPISODE
    • monthly NEW EPISODES
    • 19m AVG DURATION
    • 71 EPISODES


    Search for episodes from Targeted Talks with a specific topic:

    Latest episodes from Targeted Talks

    S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning

    Play Episode Listen Later Apr 15, 2025 36:35


     In this episode of Emerging Experts, Xiaojie Zhang, MD, a hematology/oncology fellow, and Akshat Singhal, PhD, a postdoctoral scholar, both at UC San Diego, shed light on innovative research leveraging deep learning to predict how patients with ER-positive/HER2-negative (ER+/HER2-) breast cancer will respond to palbociclib (Ibrance), a common first-line treatment for this patient population. Their work, fueled by the desire to improve precision oncology, demonstrates the significant potential of artificial intelligence (AI) in guiding cancer care. 

    S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall

    Play Episode Listen Later Mar 13, 2025 14:48


    In this episode of Targeted Talks, Alfred L. Garfall, MD, discusses the phase 2 BMT CTN 1902 trial (NCT05032820) of idecabtagene vicleucel (ide-cel; Abecma), a study focused on patients with multiple myeloma who had a suboptimal response to first-line therapy, including autologous hematopoietic cell transplant and lenalidomide (Revlimid) maintenance.

    S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain

    Play Episode Listen Later Feb 27, 2025 27:50


    David A. Russler-Germain, MD, PhD, physician-scientist at Washington University School of Medicine and Siteman Cancer Center, discusses his path in oncology and the many advancements shaping lymphoma treatment today.

    S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia

    Play Episode Listen Later Feb 6, 2025 8:13


    In this episode of Targeted Talks, Aditya Bardia, MD, MPH, FASCO, discusses the recent FDA approval of datopotamab deruxtecan for the treatment of patients with unresectable or metastatic hormone receptor-positive, HER2-negative breast cancer who have received prior systemic therapy.

    S6 Ep1: Juneja Explores AI's Impact in Early Cancer Detection and Treatment

    Play Episode Listen Later Jan 15, 2025 35:13


    In this episode of Targeted Talks, Sanjay K. Juneja, MD, hematologist & medical oncologist at Mary Bird Perkins Cancer Center, discusses the exciting advancements of artificial intelligence in 2024, specifically focusing on its transformative impact on early cancer detection.

    S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research

    Play Episode Listen Later Nov 14, 2024 16:28


    In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, discusses the transformative impact of artificial intelligence in oncology.

    S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

    Play Episode Listen Later Oct 31, 2024 27:56


    In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.

    S5 Ep18: Turning Inspiration Into Innovation: Hazim's Impact on Oncology

    Play Episode Listen Later Oct 17, 2024 16:20


    Antonious Hazim, MD, hematology medical oncology fellow at Mayo Clinic, Rochester, Minnesota, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing research.

    S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer

    Play Episode Listen Later Sep 26, 2024 13:41


    In this episode of Targeted Talks, Virginia Kaklamani, MD, DSc, professor of medicine in the Division of Hematology-Medical Oncology at The University of Texas Health Science Center San Antonio and the leader of the breast cancer program at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the background, findings, and implications of the phase 3 EMERALD trial.

    S5 Ep16: Foran Goes Beyond the Basics of BPDCN

    Play Episode Listen Later Sep 17, 2024 22:32


    In this episode of Targeted Talks, James M. Foran, MD, discusses the presentation and diagnosis of blastic plasmacytoid dendritic cell neoplasm. 

    md basics foran james m foran
    S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates

    Play Episode Listen Later Aug 30, 2024 30:43


    In this episode of Emerging Experts, Paolo Tarantino, MD, researcher at the European Institute of Oncology, and clinical research fellow at Dana-Farber Cancer Institute, discusses the latest developments in breast cancer research and treatment, focusing on the evolving understanding of HER2-low breast cancer subtypes and the potential advantages of using antibody-drug conjugates.

    S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel

    Play Episode Listen Later Aug 15, 2024 16:05


    In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.

    S5 Ep13: Cancer Research Across Continents: Fujiwara's Path From Japan to the US

    Play Episode Listen Later Aug 1, 2024 19:23


    In this episode of Emerging Experts, Yu Fujiwara, shares his journey from Japan to the United States and his path to becoming a specialist in hematology and oncology.  

    S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role

    Play Episode Listen Later Jul 15, 2024 18:04


    In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma. 

    S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine

    Play Episode Listen Later Jul 1, 2024 23:58


    Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.

    S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM

    Play Episode Listen Later Jun 14, 2024 20:11


    In this episode of Targeted Talks, Binod Dhakal, MD, MS, discusses the recent FDA approval of ciltacabtagene autoleucel for the treatment of relapsed/refractory multiple myeloma.

    S5 Ep9: Unlocking the Potential of Technology in Community Oncology

    Play Episode Listen Later May 15, 2024 25:49


    In this episode of Targeted Talks, Nini Wu, MD, MBA, chief medical and development officer at Cardinal Health, shares her insights on the ever-changing world of technology in the community oncology setting. 

    S5 Ep8: LaPelusa's Journey in the Dynamic Field of GI Oncology

    Play Episode Listen Later May 1, 2024 14:20


    In the latest episode of Emerging Experts, Michael LaPelusa, MD, hematology and oncology fellow at MD Anderson Cancer Center, shares his insights, experiences, and passion for cancer research, particularly in the realm of gastrointestinal cancers.

    S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches

    Play Episode Listen Later Apr 15, 2024 26:53


    In this episode of Targeted Talks, M. Michele Blackwood, MD, FACS, director of breast surgery, Robert Wood Johnson (RWJ), Barnabas Health, director of women's oncologic health, RWJ Barnabas Health and Rutgers Cancer Institute, and head of breast surgery, Cooperman Barnabas Medical Center, discusses the current landscape of breast cancer treatment and how personalized medicine with genomic testing is changing the field.

    S5 Ep6: Dizman's Global Pursuit to Cancer Research and Understanding

    Play Episode Listen Later Apr 1, 2024 19:05


    In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States. 

    S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC

    Play Episode Listen Later Mar 15, 2024 22:32


    In this episode, Joshua K. Sabari, MD, discusses the FDA approval of amivantamab plus chemotherapy as a first-line treatment for patients with EGFR exon 20 insertion mutation-positive non-small cell lung cancer.

    S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC

    Play Episode Listen Later Mar 1, 2024 19:03


    In this episode of Emerging Experts, Peter Zang, MD, highlights research on baseline CD8 lymph node avidity with 89-Zr-crefmirlimab for the treatment of patients with metastatic renal cell carcinoma and response to immunotherapy. 

    S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing

    Play Episode Listen Later Feb 15, 2024 22:04


    In season 5, episode 3 of Targeted Talks, Ben Derman, MD, assistant professor of medicine at the University of Chicago Medical Center, dissects the latest advancements in myeloma treatment, focusing on the role of ClonoSeq and minimal residual disease monitoring.

    S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC

    Play Episode Listen Later Feb 1, 2024 20:06


    In our 4th episode of Emerging Experts, Minas P. Economides, MD, assistant professor of medicine at NYU Langone Perlmutter Cancer Center, unveils the challenges and opportunities for renal cell carcinoma treatment, focusing on the lack of therapies available in the second-line setting.

    S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer

    Play Episode Listen Later Jan 15, 2024 23:52


    In season 5, episode 1 of Targeted Talks, Badrinath Konety, MD, president of the Allina Health Cancer Institute and the chief academic officer for Allina Health, delves into the critical topic of prostate cancer screening, particularly for men within a community setting, and discusses some of the recent advancements in the prostate cancer space.

    S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care

    Play Episode Listen Later Dec 15, 2023 15:49


    In season 4, episode 20 of Targeted Talks, Aaron Lisberg, MD, a thoracic medical oncologist at the University of California, Los Angeles, delves into findings from the phase 3 TROPION-Lung01 study of datopotamab deruxtecan for the treatment of patients with advanced or metastatic non–small cell lung cancer.

    S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities

    Play Episode Listen Later Nov 30, 2023 15:57


    In our third episode of Emerging Experts, host Jordyn Sava is joined by Matthew Hadfield, DO, a third-year hematology/oncology fellow at Brown University, to discuss his interest and research in immunotherapy toxicities. 

    S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC

    Play Episode Listen Later Nov 15, 2023 9:24


    In season 4, episode 18 of Targeted Talks, Arvind Dasari, MD, MS, dives into the recent approval of fruquintinib for patients with with metastatic colorectal cancer.

    S4 Ep17: Bridging Science and Compassion in Cancer Care

    Play Episode Listen Later Oct 31, 2023 20:24


    In this episode of Emerging Experts, host Jordyn Sava is joined by Hemali Batra-Sharma, MD, fellow, Hematology/Oncology, University of California San Diego (UCSD) Medical Center, UCSD Health, to discuss insights into her passion for oncology and some of the experiences that have helped to shape her career.

    S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer

    Play Episode Listen Later Oct 13, 2023 25:35


    In season 4, episode 16 of Targeted Talks, Susanne G. Warner, MD, hepatobiliary and pancreas surgeon at the Mayo Clinic in Rochester, Minnesota, discusses the importance of tailoring treatments for patients with liver cancer, taking into account the staging of the cancer.

    S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field

    Play Episode Listen Later Sep 29, 2023 11:50


    In our first episode of Emerging Experts, Aakash Desai, MD, MPH, discusses his journey through the oncology field by reminiscing on the encouraging guidance of his mentors, personal research goals, and his experiences thus far as an oncologist.

    S4 Ep14: First Real-World Data on Second-Generation AR Inhibitor Use in nmCRPC

    Play Episode Listen Later Sep 18, 2023 7:52


    Alicia Morgan, MD, MPH on real-world data from the DEAR study.

    S4 Ep13: Strategies for Neoadjuvant NSCLC Treatment

    Play Episode Listen Later Sep 1, 2023 10:04


    An interview with Benny Weskler, MBA, MD, FACS, FACCP of Allegheny Health Network.

    S4 Ep12: Lessons from Real-World Cases of Small Cell Lung Cancer

    Play Episode Listen Later Aug 15, 2023 16:53


    Federico Albrecht, MD discusses 2 small cell lung cancer cases.

    S4 Ep11: Social Determinants of Health Impacting Oncology Today

    Play Episode Listen Later Jul 31, 2023 10:16


    S4 Ep10: Recommendations for Treating Central Nervous Systems Cancers

    Play Episode Listen Later Jul 14, 2023 8:19


    Craig Horbinski, MD, PhD, unpacks the NCCN Clinical Practice Guidelines for central nervous system tumors.

    S4 Ep9: Mitigating Cardiotoxicity Resulting from Immune Checkpoint Inhibitor Therapy

    Play Episode Listen Later Jun 30, 2023 12:43


    In season 4, episode 9 of Targeted Talks, Kerry Reynolds, MD of Massachusetts General Hospital discusses the occurrence of myocarditis in patients with cancer treated with immune checkpoint inhibitors.

    S4 Ep8: Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer

    Play Episode Listen Later Jun 23, 2023 21:12


    S4 Ep7: Exciting Activity in Chronic Lymphocytic Leukemia

    Play Episode Listen Later May 31, 2023 8:05


    S4 Ep6: Anticipating Novel Treatments for the RAI-Refractory DTC Armamentarium

    Play Episode Listen Later May 15, 2023 8:32


    An interview with Warren Swegal, MD.

    S4 Ep5: Advancing the Treatment of Alveolar Soft Part Sarcoma

    Play Episode Listen Later Apr 26, 2023 13:16


    An interview with Alice P. Chen, MD of the National Cancer Institute.

    S4 Ep4: Understanding and Treating Mucosal Melanoma

    Play Episode Listen Later Apr 14, 2023 11:44


    Richard D. Carvajal, MD, discusses mucosal melanoma and treatment options for the disease.

    S4 Ep3: Hitting New Targets in Metastatic Prostate Cancer

    Play Episode Listen Later Mar 16, 2023 12:31


    In season 4, episode 3 of Targeted Talks, Pedro Barata, MD, MSc, discusses the present and future of prostate cancer precision medicine.

    S4 Ep2: The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment

    Play Episode Listen Later Feb 28, 2023 9:48


    A talk with Sara A. Hurvitz, MD about advances in the HER2-positive breast cancer space.

    S4 Ep1: Unpacking the Latest Research in Gastrointestinal Cancers

    Play Episode Listen Later Feb 15, 2023 17:36


    In season 4, episode 1 of Targeted Talks, Benjamin L. Schlechter, MD, of Dana-Farber Cancer Institute discuses new studies in gastrointestinal malignancies.

    S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment

    Play Episode Listen Later Nov 17, 2022 21:04


    In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.

    S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment

    Play Episode Listen Later Nov 17, 2022 21:04


    In season 3, episode 10 of Targeted Talks, Nitika Sharma, MD of Cancer Treatment Centers of America Atlanta, discusses FDA-approved and promising novel therapies for the treatment of small cell lung cancer.

    S3 Ep9: Special Episode: Managing Cardiotoxicity from ICI Therapy in Patients with Cancer

    Play Episode Listen Later Oct 25, 2022 17:45


    In season 3, episode 9 of Targeted Talks, Mohammed Salhab, MD, Chris Fine, MD, FACC, cardiologist at National Jewish Health, have a special discussion about cardiotoxicity from immune checkpoint inhibitor therapy in patients with cancer.

    S3 Ep8: Treating HER2-Positive Beast Cancer in the Community Setting

    Play Episode Listen Later Sep 16, 2022 17:24


    In season 3, episode 8 of Targeted Talks, Christie J. Hilton, DO, discusses treating first- and second-line HER2-positive breast cancer.

    S3 Ep7: The Evolution of Endometrial Cancer Treatment

    Play Episode Listen Later Aug 15, 2022 9:36


    In season 3, episode 7 of Targeted Talks, John Nakayama, MD, a gynecologic oncologist at Allegheny Health Network, discusses updates in the endometrial cancer treatment landscape.

    S3 Ep6: Examining the Non-Hodgkin Lymphoma Treatment Paradigm

    Play Episode Listen Later Jul 15, 2022 12:36


    Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.

    Claim Targeted Talks

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel